What is the recommended dose increment for Luvox (fluvoxamine) at one time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Luvox (Fluvoxamine) Dose Increment Recommendations

For adults, increase Luvox by 50 mg increments every 4-7 days; for pediatric patients (ages 8-17), increase by 25 mg increments every 4-7 days. 1

Adult Dosing Titration

  • Start at 50 mg once daily at bedtime 1
  • Increase in 50 mg increments every 4 to 7 days as tolerated until maximum therapeutic benefit is achieved 1
  • Maximum dose is 300 mg/day 1
  • Doses above 100 mg/day should be split into two divided doses, with the larger dose given at bedtime 1

Pediatric Dosing Titration (Ages 8-17)

  • Start at 25 mg once daily at bedtime 1
  • Increase in 25 mg increments every 4 to 7 days as tolerated 1
  • Maximum dose for children up to age 11: 200 mg/day 1
  • Maximum dose for adolescents: 300 mg/day 1
  • Doses above 50 mg/day should be split into two divided doses, with the larger dose given at bedtime 1

Important Gender and Age Considerations

  • Female children may achieve therapeutic effect at lower doses 1
  • Steady-state plasma concentrations are 2-3 times higher in children (ages 6-11) compared to adolescents, justifying the lower maximum dose 2, 3

Special Populations

Elderly or Hepatically Impaired Patients

  • Use slower titration and lower increments due to decreased clearance 1
  • Consider modifying both initial dose and subsequent titration schedule 1

Clinical Pearls

  • The 4-7 day interval between dose increases allows assessment of tolerability before further escalation 1
  • Therapeutic trials typically require 10 weeks at adequate dosing to assess efficacy 1
  • Nausea is the most common adverse effect (occurring in >10% of patients), but is generally mild to moderate 4, 5
  • When discontinuing, taper gradually rather than stopping abruptly to minimize withdrawal symptoms 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.